Trials Without Borders: Episode 5

In Episode 5 of Trials Without Borders, we explore Canada's clinical trial ecosystem with expert panelists Erin Cherban (Chief Clinical Research Officer, Centre Advancing Health Outcomes/CIHR Pan-Canadian Network), Melissa Bomben (CEO, True North Innovation Agency and fractional COO of Biorasi), and Sergey Nikitin (Founder and President, Prime Site Research Solutions Inc.).

This episode covers the end-to-end regulatory pathway in Canada, including Health Canada's Clinical Trial Application process and Research Ethics Board requirements. Our panelists discuss how Canada's universal healthcare system impacts patient recruitment and data quality, site selection strategies across public and private institutions, and the role of collaborative networks like Network of Networks (N2 Canada). Additional topics include contract negotiation best practices, decentralized trial adoption, cross-border collaboration, and Canada's advantages for early-phase and advanced therapy trials.